Expert panel on cost analysis of atrial fibrillation
Yıl: 2013 Cilt: 13 Sayı: 1 Sayfa Aralığı: 26 - 38 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022
Expert panel on cost analysis of atrial fibrillation
Öz: Amaç: Atriyal fibrilasyon (AF) yönetimi toplam maliyetinin klinik uygulama ve kılavuzlar bazında hesaplanarak akut koroner sendrom, kalp yetersizliği, inme ve ilaça bağlı advers olaylar açısından maliyet verilerinin sağlanması. Yöntem: Bu maliyet analiz çalışması, AF hastalarında akut koroner sendrom, kalp yetersizliği, inme ve ilaca bağlı advers olaylar bazında toplam maliyetin, kendi klinik pratikleri ve ACCF/AHA/ESC kılavuzlarında yer alan öneriler doğrultusunda araştırıcılar tarafından doldurulan standart anket formları aracılığı ile hesaplanması yolu ile yürütüldü. Toplam tıbbi maliyet hesabına dahil edilen maliyet kalemleri tedavi, sağlık kaynakları kullanımı, tanısal testler ve konsültasyon kalemleri olarak belirlendi. Bulgular: Akut koroner sendrom için hesaplanan ortalama toplam maliyet, uzmanların günlük klinik pratiği yansıtan görüşlerine göre 5.478.43 TL iken kılavuzlar doğrultusunda 11.319.44 TL olarak hesaplandı. Kalp yetersizliği toplam maliyeti uzman görüşlerine göre 4.523.74 TL iken kılavuzlar doğrultusunda 2.925.86 TL olarak hesaplandı. İnme toplam maliyeti uzman görüşlerine göre 5.719.25 TL, kılavuzlara göre ise 7.931.18 TL olarak hesaplandı. İlaca bağlı advers olaylar içinde, yalnızca kardiyak advers olaylar için, uzman görüşleri doğrultusunda kılavuzlara göre daha yüksek maliyet tespit edildi (288.65 ve 150.99 TL). Sonuç: Atriyal fibrilasyon ve ilgili advers olayların yönetiminde klinik pratikte kullanılan tedavi algoritmalarını yansıtan bulgularımız, hastalıkları kontrol altına alınamayan hastaların sağlık ekonomisine getirdiği fazladan maliyet yüküne işaret etmektedir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429. [CrossRef]
- 2. Reynolds MR, Lavelle T, Essebag V, Cohen DJ, Zimetbaum P Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. Am Heart Journal 2006; 152: 1097-103. [CrossRef]
- 3. Dorian P Jung W, Newman D, Paquette M, Wood K, Ayers GM, et al. , The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36: 1303-9. [CrossRef]
- 4. Crystal E, Connolly SJ. Atrial fibrillation: guiding lessons from epidemiology. Cardiol Clin 2004; 22: 1-8. [CrossRef]
- 5. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: 257-354.
- 6. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5. [CrossRef]
- 7. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention. Circulation 2003; 108: 711-6. [CrossRef]
- 8. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation- executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006; 27: 1979-2030. [CrossRef]
- 9. Tsang TS, Miyasaka Y, Barnes ME, Gersh BJ. Epidemiological profile of atrial fibrillation: a contemporary perspective. Prog Cardiovasc Dis 2005;48:1-8. [CrossRef]
- 10. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001; 37: 371-8. [CrossRef]
- 11. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852-923. [CrossRef]
- 12. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al; European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26: 2422- 34. [CrossRef]
- 13. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, et al; 2006 Writing Committee Members. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123: 104-23. [CrossRef]
- 14. McNamara RL, Brass LM, Drozda JP Jr, Go AS, Halperin JL, Kerr CR, et al; American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation); American College of Cardiology; American Heart Association. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation 2004; 109: 3223-43. [CrossRef]
- 15. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/ AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116: e148-304. [CrossRef]
- 16. Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, et al; American College of Cardiology/American Heart Association Task Force on Performance Measures; American Academy of Family Physicians; American College of Emergency Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Cardiovascular Angiography and Interventions; Society of Hospital Medicine. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008; 118: 2596-648.
- 17. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-292.
- 18. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909- 45. [CrossRef]
- 19. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-442. [CrossRef]
- 20. Bassand JP Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-660. [CrossRef]
- 21. Radford MJ, Arnold JM, Bennett SJ, Cinquegrani MP Cleland JG, Havranek EP et al; American College of Cardiology; American Heart Association Task Force on Clinical Data Standards; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Failure Society of America. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation 2005; 112: 1888-916. [CrossRef]
- 22. Stockburger D. Introductory statistics: concepts, models and applications. Mason, Ohio, USA: Cengage Learning-Atomic Dog Publishing; 2001.
- 23. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N. [CrossRef]
- 24. Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P Kowey PR, et al. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol 2010; 105: 687-93. [CrossRef]
- 25. Steg PG, on behalf of REALISE investigators. The RealiseAF registry: An International, observational, cross-sectional survey evaluating atrial fibrillation management and the cardiovascular risk profile of AF patients initial results. ESC Congress 2010. 28 Aug 2010 - 01 Sep 2010, Stockholm - Sweden. Available from: URL: http://www.infarktu. net/upload/files/REALISE-presenter-Slides-Steg.pdf.
| APA | Fak A, KÜÇÜKOĞLU M, FAK AFŞAR N, Demir M, AĞIR A, DEMİRTAŞ M, Köse S, Özdemir M (2013). Expert panel on cost analysis of atrial fibrillation. , 26 - 38. |
| Chicago | Fak Ali Serdar,KÜÇÜKOĞLU M. Serdar,FAK AFŞAR Nazire,Demir Mesut,AĞIR A. Ayşen,DEMİRTAŞ Mustafa,Köse Sedat,Özdemir Murat Expert panel on cost analysis of atrial fibrillation. (2013): 26 - 38. |
| MLA | Fak Ali Serdar,KÜÇÜKOĞLU M. Serdar,FAK AFŞAR Nazire,Demir Mesut,AĞIR A. Ayşen,DEMİRTAŞ Mustafa,Köse Sedat,Özdemir Murat Expert panel on cost analysis of atrial fibrillation. , 2013, ss.26 - 38. |
| AMA | Fak A,KÜÇÜKOĞLU M,FAK AFŞAR N,Demir M,AĞIR A,DEMİRTAŞ M,Köse S,Özdemir M Expert panel on cost analysis of atrial fibrillation. . 2013; 26 - 38. |
| Vancouver | Fak A,KÜÇÜKOĞLU M,FAK AFŞAR N,Demir M,AĞIR A,DEMİRTAŞ M,Köse S,Özdemir M Expert panel on cost analysis of atrial fibrillation. . 2013; 26 - 38. |
| IEEE | Fak A,KÜÇÜKOĞLU M,FAK AFŞAR N,Demir M,AĞIR A,DEMİRTAŞ M,Köse S,Özdemir M "Expert panel on cost analysis of atrial fibrillation." , ss.26 - 38, 2013. |
| ISNAD | Fak, Ali Serdar vd. "Expert panel on cost analysis of atrial fibrillation". (2013), 26-38. |
| APA | Fak A, KÜÇÜKOĞLU M, FAK AFŞAR N, Demir M, AĞIR A, DEMİRTAŞ M, Köse S, Özdemir M (2013). Expert panel on cost analysis of atrial fibrillation. Anadolu Kardiyoloji Dergisi, 13(1), 26 - 38. |
| Chicago | Fak Ali Serdar,KÜÇÜKOĞLU M. Serdar,FAK AFŞAR Nazire,Demir Mesut,AĞIR A. Ayşen,DEMİRTAŞ Mustafa,Köse Sedat,Özdemir Murat Expert panel on cost analysis of atrial fibrillation. Anadolu Kardiyoloji Dergisi 13, no.1 (2013): 26 - 38. |
| MLA | Fak Ali Serdar,KÜÇÜKOĞLU M. Serdar,FAK AFŞAR Nazire,Demir Mesut,AĞIR A. Ayşen,DEMİRTAŞ Mustafa,Köse Sedat,Özdemir Murat Expert panel on cost analysis of atrial fibrillation. Anadolu Kardiyoloji Dergisi, vol.13, no.1, 2013, ss.26 - 38. |
| AMA | Fak A,KÜÇÜKOĞLU M,FAK AFŞAR N,Demir M,AĞIR A,DEMİRTAŞ M,Köse S,Özdemir M Expert panel on cost analysis of atrial fibrillation. Anadolu Kardiyoloji Dergisi. 2013; 13(1): 26 - 38. |
| Vancouver | Fak A,KÜÇÜKOĞLU M,FAK AFŞAR N,Demir M,AĞIR A,DEMİRTAŞ M,Köse S,Özdemir M Expert panel on cost analysis of atrial fibrillation. Anadolu Kardiyoloji Dergisi. 2013; 13(1): 26 - 38. |
| IEEE | Fak A,KÜÇÜKOĞLU M,FAK AFŞAR N,Demir M,AĞIR A,DEMİRTAŞ M,Köse S,Özdemir M "Expert panel on cost analysis of atrial fibrillation." Anadolu Kardiyoloji Dergisi, 13, ss.26 - 38, 2013. |
| ISNAD | Fak, Ali Serdar vd. "Expert panel on cost analysis of atrial fibrillation". Anadolu Kardiyoloji Dergisi 13/1 (2013), 26-38. |
